This has to be one of the more bizarre stats to surface in recent months.
It turns out that sales of anti-cholesterol drug Lipitor actually eclipsed the entire recorded music industry last year in the US. Take a look:
*2009 US sales of recorded music: $4.6 billion
(source: IFPI’s Recording Industry In Numbers)
*2009 sales of Liptor (US): $5.4 billion
(source: Pfizer financial filings)